Research feed

Latest Diabetes Research

Recently added diabetes research, organized by intervention and outcome.

Sorted by when Dediabetes added each study.

Last updated: Sep 12, 20261,338 studies indexed

July 2026

Added to Dediabetes Jul 13, 2026RCTs

Glucose variability increases with age in type 2 diabetes patients

This study characterized continuous glucose monitoring data in patients with Type 2 diabetes in China, revealing associations between glycemic metrics and various factors.

Interventions
Acarbose
Outcomes
Coefficient of variationFasting insulin levelsMean amplitude of glycemic excursions (MAGE)+4 more
Added to Dediabetes Jul 13, 2026RCTs

Insulin therapy improves glycemic control in hospitalized T2D patients

This study evaluated the use of insulin degludec and insulin aspart guided by a clinical decision support system for glycemic control in hospitalized patients with type 2 diabetes, finding a significant percentage of blood glucose measurements within target range.

Interventions
Insulin therapy
Outcomes
Adherence to insulin dosing recommendationsBlood glucosePercentage of blood glucose measurements within target range of 3.9–7.8 mmol/L+1 more
Added to Dediabetes Jul 13, 2026RCTs

Open-source AID improves glycemic control in type 2 diabetes during surgery

This study evaluated an open-source hybrid closed-loop automated insulin delivery system in perioperative patients with Type 2 diabetes, finding it significantly improved glucose control compared to conventional insulin pump therapy.

Interventions
Hybrid closed-loop systemInsulin therapy
Outcomes
Mean glucose from rtCGMPercentage of time in target glucose range 3.9–10.0 mmol/LTime above range+2 more
Added to Dediabetes Jul 13, 2026RCTs

Semaglutide improves glycemic control in type 1 diabetes

This study evaluated the effects of semaglutide on glycemic control in adults with Type 1 diabetes using automated insulin delivery. Semaglutide improved the percentage of time spent in the target glucose range significantly.

Interventions
Semaglutide
Outcomes
Episodes of recurrent euglycemic ketosis without acidosisPercentage of time spent with sensor glucose levels <3.9 mmol/LTime in range+1 more
Added to Dediabetes Jul 13, 2026RCTs

Semaglutide reduces insulin needs in type 1 diabetes

The study investigated the impact of semaglutide on insulin needs in individuals with type 1 diabetes using pump therapy, revealing significant reductions in insulin requirements.

Interventions
Semaglutide
Outcomes
Basal insulin doseDaily bolus insulin requirementsDiabetic neuropathy incidence+5 more
Added to Dediabetes Jul 13, 2026RCTs

Sitagliptin improves kidney function in type 1 diabetes

This study evaluated the impact of sitagliptin on diabetic nephropathy in adolescents with type 1 diabetes, finding significant improvements in several metabolic parameters.

Interventions
Sitagliptin
Outcomes
Change in insulin-to-carbohydrate ratioCoefficient of variationMean sensor glucose+5 more
Added to Dediabetes Jul 13, 2026RCTs

Smart insulin software improves glycemic control in T2DM patients.

This study evaluated the effectiveness of smart insulin dosage software versus traditional physician experience in managing hyperglycemia in T2DM patients receiving insulin treatment, finding significant advantages for the software.

Interventions
Smart insulin dosage software (App group)
Outcomes
Blood glucoseGlycemia risk indexIncidence of hypoglycemia+4 more
Added to Dediabetes Jul 13, 2026RCTs

Switching to CGM Improves Glycaemic Quality in Type 1 Diabetes

This study evaluated the impact of switching from self-monitoring of blood glucose (SMBG) to continuous glucose monitoring (CGM) in adults with Type 1 diabetes, finding significant improvements in glycaemic quality.

Interventions
Continuous glucose monitoringSelf-monitoring of blood glucose
Outcomes
GRI Zone Classification Maintenance or ImprovementGlycemia risk index
Added to Dediabetes Jul 13, 2026RCTs

Tubeless AID system improves glycemic outcomes in type 1 diabetes

This study evaluated the efficacy and safety of the Tubeless Omnipod 5 automated insulin delivery system compared to traditional pump therapy with continuous glucose monitoring in adults with Type 1 diabetes.

Interventions
Hybrid closed-loop system
Outcomes
Diabetic ketoacidosisHbA1cHypoglycemia events+3 more

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.